Does LENVATINIB Cause Hyperthyroidism? 231 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 231 reports of Hyperthyroidism have been filed in association with LENVATINIB (Lenvima). This represents 0.7% of all adverse event reports for LENVATINIB.
231
Reports of Hyperthyroidism with LENVATINIB
0.7%
of all LENVATINIB reports
18
Deaths
134
Hospitalizations
How Dangerous Is Hyperthyroidism From LENVATINIB?
Of the 231 reports, 18 (7.8%) resulted in death, 134 (58.0%) required hospitalization, and 12 (5.2%) were considered life-threatening.
Is Hyperthyroidism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENVATINIB. However, 231 reports have been filed with the FAERS database.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Hyperthyroidism?
LEVOTHYROXINE (1,681)
AMIODARONE (1,410)
NIVOLUMAB (934)
PEMBROLIZUMAB (780)
IPILIMUMAB (525)
CARBOPLATIN (432)
ATEZOLIZUMAB (416)
PACLITAXEL (261)
ALEMTUZUMAB (236)
PREDNISONE (220)
Which LENVATINIB Alternatives Have Lower Hyperthyroidism Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE